3
20
Growth Score 3 in past quarter
0 pts
Heat Score 20 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies.
Sergey Axenovich: DirectorPast Role: Burrill & Company, Director
David Wetherell: Founder & Managing DirectorPast Role: Burrill & Company, Managing Partner
About the Company
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to
collaborate with them in accelerating growth and building successful business ventures. Biomark Capital was previously known as GBP Capital.